Nicholas A Saccomano Reneo Pharmaceuticals, Inc. (RPHM) insider trading activity
Nicholas A Saccomano is President and CEO of Reneo Pharmaceuticals, Inc.. Currently has a direct ownership of 3,594 shares of RPHM, which is worth approximately $6,037. The most recent transaction as insider was on Jun 23, 2025, when has been sold 88 shares (Class A Common Stock) at a price of $2.38 per share, resulting in proceeds of $209. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
3.59K
14.39%
3M change
n/a
12M change
Total Value Held
$6,037
Nicholas A Saccomano Transaction History
NAS
Nicholas A Saccomano
President and CEO
Boulder, CO